《國企紅籌》復星醫藥（０２１９６）累斥３２３２萬人幣回購Ａ股

　　《經濟通通訊社３日專訊》復星醫藥（０２１９６）（滬：６００１９６）公布，根據回購
方案，於６月２５日通過集中競價交易首次實施Ａ股回購。截至６月３０日，累斥約
３２３２﹒４萬元（人民幣．下同）回購約１４５﹒７８萬股Ａ股，佔０﹒０５４６％股權。
　　該集團指，每股回購最高價２２﹒３２元，而最低價２２﹒０３元。（ｗｈ）

【香港好去處】etnet全新頻道盛大推出！全港最齊盛事活動資訊盡在掌握！► 即睇

返回全日新聞

回頁頂

經濟通
強化版MQ
強化版TQ
財曆
Mobile
Web

客務熱線︰(852) 2880 7004 客務郵箱︰cs@etnet.com.hk
關於我們 | 產品服務 | 廣告查詢 | 聯絡我們 | 私隱政策 | 使用條款 | 網站導航 | 有用連結 | RSS新聞

Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.

《經濟通》所刊的署名及／或不署名文章，相關內容屬作者個人意見，並不代表《經濟通》立場，《經濟通》所扮演的角色是提供一個自由言論平台。